<!--
Generated by CaseThread CLI POC
Document Type: technology-transfer-agreement
Input File: cil-06-tech-transfer-manufacturing.yaml
Generated: 2025-07-09T01:09:02.779Z
Generation Time: 37s
-->

TECHNOLOGY TRANSFER AGREEMENT
================================

This Technology Transfer Agreement ("Agreement") is entered into as of March 15, 2024 ("Effective Date") by and between:

ChemInnovate Labs, Inc. ("Provider"), a corporation organized under the laws of Delaware, and

EcoWrap Industries, LLC ("Recipient"), a corporation organized under the laws of Texas.

Provider and Recipient may be referred to individually as a "Party" and collectively as the "Parties."

---

### WHEREAS CLAUSES

WHEREAS, Provider has developed and owns certain technology in the field of Biodegradable Polymer Manufacturing;

WHEREAS, Recipient desires to obtain rights to such technology for commercialization;

WHEREAS, Provider is willing to transfer such technology and provide associated know-how and support;

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the Parties agree as follows:

---

## 1. DEFINITIONS

1.1 "Technology" means the manufacturing process for BioPoly-X™ polymer production, quality control protocols and specifications, extrusion parameters for film production, formulation adjustments for different applications, and troubleshooting guides and best practices, including all related process documentation, know-how, quality control protocols, extrusion parameters, formulation guidelines, troubleshooting documentation.

1.2 "Know-How" means all technical information, data, materials, trade secrets, and expertise related to the Technology.

1.3 "Confidential Information" means all non-public information disclosed by either Party.

1.4 "Territory" means: Worldwide.

---

## 2. TECHNOLOGY TRANSFER

2.1 Grant of Rights. Provider hereby grants to Recipient an exclusive license to the Technology in the Territory.

2.2 Delivery. Provider shall deliver to Recipient within thirty (30) days:

(a) All documentation related to the Technology;  
(b) Physical materials and samples;  
(c) Know-How in written and electronic form.

2.3 Transfer Method. Delivery shall be made via secure file transfer and physical shipment with appropriate confidentiality protections.

---

## 3. TRAINING AND SUPPORT

3.1 Training Program. Provider shall provide on-site training for up to eight (8) technical staff members of Recipient at Recipient’s Houston facility for a duration of two (2) weeks covering:  
• Equipment operation and maintenance  
• Process optimization  
• Quality testing procedures  
• Safety protocols

3.2 Technical Support. Provider shall provide reasonable remote technical support for twelve (12) months after completion of the initial training.

3.3 Documentation. Provider shall furnish comprehensive technical documentation and updates during the support period.

---

## 4. FINANCIAL TERMS

4.1 Technology Transfer Fee. Recipient shall pay Provider Seven Hundred Fifty Thousand United States Dollars (US $750,000) within thirty (30) days of the Effective Date.

4.2 Payment Schedule. The Technology Transfer Fee shall be paid in the following installments:  
(a) US $250,000 upon execution of this Agreement;  
(b) US $250,000 upon delivery of the documentation package;  
(c) US $250,000 upon completion of training.

4.3 Payment Terms. All payments shall be made in U.S. dollars via wire transfer. Late payments bear interest at one and one-half percent (1.5 %) per month or the maximum allowed by law, whichever is lower.

---

## 5. ACCEPTANCE

5.1 Acceptance Period. Recipient shall have sixty (60) days after delivery to test and evaluate the Technology.

5.2 Acceptance Criteria. The Technology shall be deemed accepted if it meets the specifications set forth in Exhibit A (Performance Standards).

5.3 Remedies. If the Technology fails acceptance, Provider shall have thirty (30) days to cure any deficiencies.

5.4 Deemed Acceptance. The Technology shall be deemed accepted if Recipient fails to provide written notice of deficiencies within the acceptance period.

---

## 6. INTELLECTUAL PROPERTY

6.1 Ownership. Provider retains all ownership rights in the Technology.

6.2 Improvements. Recipient owns all improvements made to the Technology, and Provider is granted a non-exclusive, royalty-free license to practice such improvements.

6.3 No Other Rights. No intellectual property rights are granted except as expressly stated herein.

---

## 7. CONFIDENTIALITY

7.1 Obligations. Each Party shall maintain the other Party’s Confidential Information in strict confidence for ten (10) years from the Effective Date.

7.2 Exceptions. Confidentiality obligations do not apply to information that:  
(a) is or becomes publicly available without breach of this Agreement;  
(b) was rightfully known to the receiving Party before disclosure;  
(c) is independently developed without use of Confidential Information; or  
(d) is required to be disclosed by law or court order, provided that the disclosing Party is given prompt notice and an opportunity to seek protective measures.

7.3 Return. Upon termination or expiration of this Agreement, each Party shall promptly return or destroy all Confidential Information of the other Party.

---

## 8. EXPORT CONTROL

8.1 Compliance. Both Parties shall comply with all applicable export control laws and regulations.

8.2 Classification. The Technology is classified as EAR99 under U.S. export regulations.

8.3 Restrictions. Recipient shall not export, re-export, or transfer the Technology without all required governmental licenses and approvals.

8.4 Certifications. Recipient certifies it is not listed on any U.S. or international prohibited party lists.

---

## 9. WARRANTIES AND INDEMNIFICATION

9.1 Provider Warranties. Provider represents and warrants that:  
(a) it has the right and authority to transfer the Technology;  
(b) to Provider’s knowledge, the Technology does not infringe any third-party intellectual property rights; and  
(c) the Technology will perform materially in accordance with the description in this Agreement for a period of one (1) year from acceptance.

9.2 Disclaimer. EXCEPT AS EXPRESSLY PROVIDED IN SECTION 9.1, THE TECHNOLOGY IS PROVIDED "AS IS," AND PROVIDER DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.

9.3 Indemnification. Each Party shall indemnify, defend, and hold harmless the other Party from and against any third-party claims, losses, or damages arising out of a breach of its warranties or representations under this Agreement.

9.4 Limitation of Liability. Except for breaches of confidentiality or indemnification obligations, each Party’s liability for direct damages shall not exceed the total Technology Transfer Fee. Neither Party shall be liable for any indirect, consequential, or punitive damages.

---

## 10. TERM AND TERMINATION

10.1 Term. This Agreement shall remain in force for ten (10) years from the Effective Date unless earlier terminated as provided herein.

10.2 Termination for Breach. Either Party may terminate this Agreement upon sixty (60) days’ written notice if the other Party materially breaches any provision of this Agreement and fails to cure such breach within the notice period.

10.3 Effect of Termination. Upon termination:  
(a) all licenses granted under this Agreement shall terminate;  
(b) each Party shall cease use of the other Party’s Confidential Information, except as required to perform post-termination obligations;  
(c) accrued payment obligations shall survive; and  
(d) Sections 7, 9, 10.3, and 11 shall survive termination or expiration.

---

## 11. GENERAL PROVISIONS

11.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflict-of-law principles.

11.2 Dispute Resolution. Any dispute arising out of or relating to this Agreement shall be finally resolved by binding arbitration under the rules of the American Arbitration Association (AAA). The arbitration shall be conducted in English in Wilmington, Delaware, by a panel of three (3) arbitrators. Judgment on the award may be entered in any court of competent jurisdiction.

11.3 Entire Agreement. This Agreement, together with all exhibits, constitutes the entire understanding between the Parties with respect to the subject matter hereof and supersedes all prior oral or written agreements.

11.4 Assignment. Neither Party may assign or transfer this Agreement without the prior written consent of the other Party, except to an affiliate or successor in connection with a merger, acquisition, or sale of substantially all assets, provided that the assigning Party provides written notice to the other Party.

11.5 Amendments. Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both Parties.

11.6 Severability. If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect.

11.7 Notices. All notices required under this Agreement shall be in writing and deemed given when delivered personally, by recognized overnight courier, or by certified mail (return receipt requested) to the addresses first written above or such other address as either Party may designate in writing.

---

## 12. SIGNATURES

IN WITNESS WHEREOF, the Parties have executed this Technology Transfer Agreement as of the Effective Date.

**PROVIDER**  
ChemInnovate Labs, Inc.  

By: _____________________________  
Name: Dr. James Liu  
Title: CEO  
Date: ___________________________

**RECIPIENT**  
EcoWrap Industries, LLC  

By: _____________________________  
Name: Maria Santos  
Title: President  
Date: ___________________________

---

*Matter No.: CIL-2024-TECH01*